These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6743473)

  • 1. Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
    Verbeeck RK; Wallace SM; Loewen GR
    Br J Clin Pharmacol; 1984 Jun; 17(6):783-4. PubMed ID: 6743473
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats.
    Meunier CJ; Verbeeck RK
    Drug Metab Dispos; 1999 Jan; 27(1):26-31. PubMed ID: 9884306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probenecid on ketoprofen kinetics.
    Upton RA; Williams RL; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1982 Jun; 31(6):705-12. PubMed ID: 7075118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
    Abas A; Meffin PJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation and elimination of diflunisal in the isolated perfused rat liver: effect of pretreatment with phenobarbitone, clofibric acid and spironolactone.
    Faed EM; Dobbs BR; Lee D
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):4-16. PubMed ID: 6517647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ketoprofen in the elderly.
    Advenier C; Roux A; Gobert C; Massias P; Varoquaux O; Flouvat B
    Br J Clin Pharmacol; 1983 Jul; 16(1):65-70. PubMed ID: 6882624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A renal mechanism for the clofibric acid-probenecid interaction.
    Meffin PJ; Zilm DM; Veenendaal JR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):739-42. PubMed ID: 6655567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G; Larsen HW; Hansen H; Sørensen
    Scand J Rheumatol; 1981; 10(3):189-92. PubMed ID: 7291952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.
    Macdonald JI; Wallace SM; Mahachai V; Verbeeck RK
    Eur J Clin Pharmacol; 1992; 42(5):471-4. PubMed ID: 1606992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic profil of ketoprofen (author's transl)].
    Caillé G; Besner JG; Brodeur J; Vezina M
    Ann Pharm Fr; 1978; 36(5-6):243-52. PubMed ID: 707953
    [No Abstract]   [Full Text] [Related]  

  • 13. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity and enantioselectivity of arylcarboxylic acid glucuronidation.
    Fournel-Gigleux S; Hamar-Hansen C; Motassim N; Antoine B; Mothe O; Decolin D; Caldwell J; Siest G
    Drug Metab Dispos; 1988; 16(4):627-34. PubMed ID: 2903034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of ketoprofen in patients with renal failure].
    Stafanger G; Larsen HW; Hansen H; Serensen K
    Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and therapeutic effects of ketoprofen.
    Sala G; Silvestri N; Castegnaro E; Pollini C
    Farmaco Prat; 1978 Oct; 33(10):455-60. PubMed ID: 312213
    [No Abstract]   [Full Text] [Related]  

  • 20. Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.
    Miners JO; Robson RA; Birkett DJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):240-3. PubMed ID: 6487463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.